Emerging Diseases, Zoonoses and Public Health, and Veterinary Pathology. She received a DVM from the University of Guelph and a PhD from the University of California, Davis. Dr. Brown has served on three National Academies committees: the Committee on Genomics Databases for Bioterrorism Threat Agents: Striking a Balance for Information Sharing (2003-2004); the Committee on Assessing the Nation’s Framework for Addressing Animal Diseases (2003-2004); and the Committee on Achieving Sustainable Global Capacity for Surveillance and Response to Emerging Diseases of Zoonotic Origin (2008).

Martha Brumfield, PhD, has a consulting practice focusing on concordance in global regulatory requirements and providing educational workshops toward that goal. Other areas of focus include excellence in clinical trial conduct and facilitation of scientific consortia and programs supporting patient access to medicines.

At present she is engaged with the non-profit Critical Path Institute as a consultant to guide international program development and to provide regulatory guidance to consortia. She is also engaged with other non-profits, Regulatory Harmonization Institute and GlobalMD, to deliver educational workshops on regulatory and clinical trial topics in Asia.

Most recently, Dr. Brumfield was senior vice president, Worldwide Regulatory Affairs and Quality Assurance at Pfizer, Inc. She led a global team that supported lifecycle pharmaceutical research, development, and commercialization through creation and implementation of regulatory strategies and quality assurance oversight. Dr. Brumfield also played a key role in managing the broader company relationships with global regulators, trade associations, academics, and others on regulatory policy issues. Dr. Brumfield has been active in several external organizations including PhRMA, the CMR International Institute for Regulatory Science, and the Asia-Pacific Economic Cooperation Life Sciences Innovation Forum and has worked extensively with the PhRMA Simultaneous Global Development program. During 20 years at Pfizer, Dr. Brumfield held a variety of leadership positions in which she led regulatory teams responsible for the United States, Europe, and emerging markets. Dr. Brumfield also served as the company’s head of drug safety surveillance and reporting, and managed global adverse event reporting requirements and the integration of Pharmacia’s related safety operations. Dr. Brumfield earned a BS and MS in Chemistry from Virginia Commonwealth University, a PhD in organic chemistry from the University of Maryland, and served as a postdoctoral fellow at the Rockefeller University.

Robert Buchanan, MS, MPhil, PhD, is director of the University of Maryland’s AGNR Center for Food Safety and Security Systems, received

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement